Genetic analysis of the most common type of bladder cancer yields guidance on treatment options

A comprehensive genomic analysis in more than 200 patients with metastatic urothelial carcinomas may help inform how a patient would respond to immunotherapy, report UNC Lineberger Comprehensive Cancer Center researchers and colleagues. About 90% of urothelial carcinomas are bladder cancers. These results, derived from a computational model based on the initial molecular findings of the UC-GENOME study, are published in Nature Communications.

source https://medicalxpress.com/news/2022-11-genetic-analysis-common-bladder-cancer.html